Indeed, central nodes in the TMZ resistance network participate of the PI3K-Akt-mTOR and Ras-Raf-Erk pathways, major downstream pathways activated by growth factors during glioma progression20, 21. Here, MAPK1 is linked to central nervous system cancer.